Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.810606458278956e-29,15.233766233766234,993.3046953623907,"['RPL30', 'RPL32', 'RPL34', 'RPL10A', 'RPL8', 'RPL9', 'RPL7', 'RPS15', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL41', 'RPL35A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24']",1.10643948540416e-26,0,0,56
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.659848700474225e-19,14.692094313453536,617.2989151047601,"['COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5']",6.508826005545359e-17,0,0,36
3,Nonalcoholic fatty liver disease WP4396,2.7063520262381037e-15,10.38152610441767,348.22934463087745,"['NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'COX8A', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'CYCS']",2.0748698867825462e-13,0,0,33
4,Mitochondrial CIV Assembly WP4922,4.422582975636007e-10,27.3094688221709,588.2221178342771,"['COX8A', 'COA3', 'COX7B', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'COX14']",2.542985210990704e-08,0,0,15
5,Mitochondrial complex I assembly model OXPHOS system WP4324,4.947056010366312e-08,11.684262619597492,196.5513581973412,"['NDUFA8', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",2.2756457647685035e-06,0,0,15
6,Oxidative phosphorylation WP623,6.22380178871591e-07,7.271604938271605,103.9091600580935,"['ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA4', 'NDUFA2', 'NDUFB2', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",2.3857906856744323e-05,0,0,16
7,Pyrimidine metabolism WP4022,0.00012325900287686635,8.070615034168565,72.6454032651052,"['POLD2', 'POLE3', 'NME2', 'POLR2I', 'DCK', 'DCTPP1', 'POLR2J', 'POLR2K', 'POLR2L']",0.00404993866595418,0,0,9
8,Mitochondrial complex III assembly WP4921,0.007201903399845106,6.670428893905192,32.90796012125721,"['UQCRB', 'UQCRQ', 'UQCR11', 'UQCR10', 'UQCRH']",0.2070547227455468,0,0,5
9,Selenium Micronutrient Network WP15,0.011192554884408932,3.742857142857143,16.814809908802257,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'SEPHS2', 'SELENOH']",0.2860319581571172,0,0,7
10,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.014115350351482684,15.957303370786518,67.98596967776369,"['BAD', 'FOXO4', 'HRAS']",0.3246530580841017,0,0,3
11,Hippo-Yap signaling pathway WP4537,0.025262230031468633,inf,inf,"['YWHAQ', 'NDRG1']",0.5282102642943441,0,0,2
12,Base Excision Repair WP4752,0.05501798169024816,5.314606741573034,15.412865540239899,"['NEIL2', 'POLD2', 'POLE3']",0.8204832739212444,0,0,3
13,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.05501798169024816,5.314606741573034,15.412865540239899,"['YWHAQ', 'FOXO4', 'NDRG1']",0.8204832739212444,0,0,3
14,Synaptic Vesicle Pathway WP2267,0.05773583526676873,2.9583646852269876,8.436892902861416,"['AP2S1', 'PARK7', 'CPLX2', 'AP2M1', 'VAMP2']",0.8204832739212444,0,0,5
15,DNA Repair Pathways Full Network WP4946,0.05993083375606706,3.5465465465465464,9.981982774882225,"['NEIL2', 'CENPX', 'POLD2', 'POLE3']",0.8204832739212444,0,0,4
16,Non-small cell lung cancer WP4255,0.05993083375606706,3.5465465465465464,9.981982774882225,"['GADD45B', 'BAD', 'CYCS', 'HRAS']",0.8204832739212444,0,0,4
17,Type 2 papillary renal cell carcinoma WP4241,0.06777905306305933,10.614349775784753,28.568544538045902,"['EGLN2', 'ELOB']",0.8204832739212444,0,0,2
18,DNA Mismatch Repair WP531,0.06777905306305933,10.614349775784753,28.568544538045902,"['POLD2', 'POLE3']",0.8204832739212444,0,0,2
19,Nucleotide metabolism WP404,0.06777905306305933,10.614349775784753,28.568544538045902,"['NME2', 'OAZ1']",0.8204832739212444,0,0,2
20,IL-3 signaling pathway WP286,0.08516531817353733,3.9842696629213483,9.813897614164038,"['YWHAQ', 'BAD', 'HRAS']",0.9415014663676738,0,0,3
21,VEGFA-VEGFR2 Signaling Pathway WP3888,0.08721694221309759,1.4632744304875454,3.5694482501051814,"['SET', 'SDF2L1', 'CRIP2', 'FOXO4', 'TXN', 'RPL10A', 'NDRG1', 'RPL7', 'DNAJA1', 'RPL18A', 'TMSB4X', 'AP2S1', 'PGK1', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'TMSB10', 'HRAS', 'PTMA', 'ARF6']",0.9415014663676738,0,0,21
22,EGF/EGFR signaling pathway WP437,0.10581160890033518,1.962406015037594,4.407750418061489,"['NDUFA13', 'AP2S1', 'NEDD8', 'FOXO4', 'HRAS', 'AP2M1', 'ARF6']",0.9415014663676738,0,0,7
23,Copper homeostasis WP3286,0.12068531722937514,3.1860674157303372,6.737158768228794,"['COX17', 'MT3', 'ATOX1']",0.9415014663676738,0,0,3
24,MET in type 1 papillary renal cell carcinoma WP4205,0.12068531722937514,3.1860674157303372,6.737158768228794,"['BAD', 'RPL11', 'HRAS']",0.9415014663676738,0,0,3
25,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.12144280676957665,5.304932735426009,11.184452566549663,"['COX8A', 'COX5A']",0.9415014663676738,0,0,2
26,Cellular Proteostasis WP4918,0.12144280676957665,5.304932735426009,11.184452566549663,"['PFDN2', 'PFDN5']",0.9415014663676738,0,0,2
27,Nucleotide Excision Repair WP4753,0.12144280676957665,5.304932735426009,11.184452566549663,"['POLD2', 'POLE3']",0.9415014663676738,0,0,2
28,Cell cycle WP179,0.1459674474468762,1.8772957146659568,3.6126146422571024,"['CDKN2D', 'GADD45B', 'YWHAQ', 'ANAPC11', 'YWHAH', 'SMC1B']",0.9415014663676738,0,0,6
29,FOXP3 in COVID-19 WP5063,0.15909065273652517,inf,inf,['IL6ST'],0.9415014663676738,0,0,1
30,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.15909065273652517,inf,inf,['ELOB'],0.9415014663676738,0,0,1
31,Homologous recombination WP186,0.15909065273652517,inf,inf,['POLD2'],0.9415014663676738,0,0,1
32,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.15909065273652517,inf,inf,['IL6ST'],0.9415014663676738,0,0,1
33,Mitochondrial CII Assembly WP4920,0.15909065273652517,inf,inf,['SDHAF1'],0.9415014663676738,0,0,1
34,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.15909065273652517,inf,inf,['IL6ST'],0.9415014663676738,0,0,1
35,Osteoclast Signaling WP12,0.15909065273652517,inf,inf,['ATP6V1G1'],0.9415014663676738,0,0,1
36,Eukaryotic Transcription Initiation WP405,0.16053991680412827,2.653932584269663,4.854607093885973,"['POLR2I', 'POLR2J', 'POLR2K']",0.9415014663676738,0,0,3
37,Cardiac Progenitor Differentiation WP2406,0.18164598292610126,3.5351270553064276,6.029850787129707,"['MESP1', 'SCN5A']",0.9415014663676738,0,0,2
38,GABA receptor Signaling WP4159,0.18164598292610126,3.5351270553064276,6.029850787129707,"['AP2S1', 'AP2M1']",0.9415014663676738,0,0,2
39,Proteoglycan biosynthesis WP4784,0.18164598292610126,3.5351270553064276,6.029850787129707,"['B3GAT3', 'XYLT1']",0.9415014663676738,0,0,2
40,Cytosolic DNA-sensing pathway WP4655,0.2036581045773567,2.273836276083467,3.618384428070232,"['IL18', 'POLR2K', 'POLR2L']",0.9415014663676738,0,0,3
41,Leptin signaling pathway WP2034,0.2036581045773567,2.273836276083467,3.618384428070232,"['BAD', 'CFL2', 'HRAS']",0.9415014663676738,0,0,3
42,mRNA Processing WP411,0.20578786884539924,1.9303849303849303,3.0517636891079354,"['SRSF3', 'SNRPE', 'HNRNPA1', 'SRSF9']",0.9415014663676738,0,0,4
43,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.2449599916032979,2.6502242152466366,3.727965405283465,"['BANF1', 'HRAS']",0.9415014663676738,0,0,2
44,Histone Modifications WP2369,0.2449599916032979,2.6502242152466366,3.727965405283465,"['SET', 'H3F3B']",0.9415014663676738,0,0,2
45,Parkinson's disease pathway WP2371,0.2449599916032979,2.6502242152466366,3.727965405283465,"['CYCS', 'PARK7']",0.9415014663676738,0,0,2
46,Endometrial cancer WP4155,0.2490082723975921,1.9887640449438202,2.764917319373618,"['GADD45B', 'BAD', 'HRAS']",0.9415014663676738,0,0,3
47,Senescence and Autophagy in Cancer WP615,0.26495246417937224,1.5608816890187227,2.073170628915526,"['GABARAPL2', 'GABARAPL1', 'IL6ST', 'HRAS', 'GABARAP']",0.9415014663676738,0,0,5
48,Ras signaling WP4223,0.26495246417937224,1.5608816890187227,2.073170628915526,"['GNG3', 'BAD', 'FOXO4', 'HRAS', 'ARF6']",0.9415014663676738,0,0,5
49,Alzheimer's disease WP2059,0.2800656985993155,1.632016632016632,2.077118266949805,"['ATP5MD', 'BAD', 'CYCS', 'ATP2A1']",0.9415014663676738,0,0,4
50,IL-18 signaling pathway WP4754,0.2858704213447232,1.2958013141775253,1.6226239717014435,"['NRN1', 'BAD', 'TMSB4X', 'COX17', 'IL18', 'CYCS', 'NDUFC1', 'RND2', 'PTMS', 'ARF6']",0.9415014663676738,0,0,10
51,Dual hijack model of Vif in HIV infection WP3300,0.292919040440952,5.295302013422819,6.501884344165859,['ELOB'],0.9415014663676738,0,0,1
52,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.292919040440952,5.295302013422819,6.501884344165859,['HRAS'],0.9415014663676738,0,0,1
53,Gastric Cancer Network 2 WP2363,0.292919040440952,5.295302013422819,6.501884344165859,['S100A6'],0.9415014663676738,0,0,1
54,Glycosaminoglycan degradation WP4815,0.292919040440952,5.295302013422819,6.501884344165859,['HYAL1'],0.9415014663676738,0,0,1
55,IL1 and megakaryocytes in obesity WP2865,0.292919040440952,5.295302013422819,6.501884344165859,['IL18'],0.9415014663676738,0,0,1
56,MTHFR deficiency WP4288,0.292919040440952,5.295302013422819,6.501884344165859,['CYCS'],0.9415014663676738,0,0,1
57,Nanoparticle-mediated activation of receptor signaling WP2643,0.292919040440952,5.295302013422819,6.501884344165859,['HRAS'],0.9415014663676738,0,0,1
58,Amyotrophic lateral sclerosis (ALS) WP2447,0.30887785589660904,2.1192825112107623,2.489752948863411,"['BAD', 'NEFH']",0.9415014663676738,0,0,2
59,Computational Model of Aerobic Glycolysis WP4629,0.30887785589660904,2.1192825112107623,2.489752948863411,"['TPI1', 'PGK1']",0.9415014663676738,0,0,2
60,Cori Cycle WP1946,0.30887785589660904,2.1192825112107623,2.489752948863411,"['TPI1', 'PGK1']",0.9415014663676738,0,0,2
61,DNA damage response WP707,0.30887785589660904,2.1192825112107623,2.489752948863411,"['GADD45B', 'CYCS']",0.9415014663676738,0,0,2
62,miRNA regulation of DNA damage response WP1530,0.30887785589660904,2.1192825112107623,2.489752948863411,"['GADD45B', 'CYCS']",0.9415014663676738,0,0,2
63,Oxidative Damage WP3941,0.30887785589660904,2.1192825112107623,2.489752948863411,"['BAD', 'CYCS']",0.9415014663676738,0,0,2
64,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.34272319737067247,1.5896629213483147,1.7022621835069094,"['GADD45B', 'BAD', 'CYCS']",0.9415014663676738,0,0,3
65,Melanoma WP4685,0.34272319737067247,1.5896629213483147,1.7022621835069094,"['GADD45B', 'BAD', 'HRAS']",0.9415014663676738,0,0,3
66,AGE/RAGE pathway WP2324,0.3716086873129143,1.765321375186846,1.7475161570014175,"['CYCS', 'FOXO4']",0.9415014663676738,0,0,2
67,IL-6 signaling pathway WP364,0.3716086873129143,1.765321375186846,1.7475161570014175,"['BAD', 'IL6ST']",0.9415014663676738,0,0,2
68,Interleukin-11 Signaling Pathway WP2332,0.3716086873129143,1.765321375186846,1.7475161570014175,"['IL6ST', 'HRAS']",0.9415014663676738,0,0,2
69,Kit receptor signaling pathway WP304,0.3716086873129143,1.765321375186846,1.7475161570014175,"['BAD', 'HRAS']",0.9415014663676738,0,0,2
70,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.3716086873129143,1.765321375186846,1.7475161570014175,"['NDUFA13', 'IL18']",0.9415014663676738,0,0,2
71,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.3716086873129143,1.765321375186846,1.7475161570014175,"['BAD', 'HRAS']",0.9415014663676738,0,0,2
72,Hepatitis B infection WP4666,0.3965877851916201,1.3243243243243243,1.2248117634296554,"['YWHAQ', 'BAD', 'CYCS', 'HRAS']",0.9415014663676738,0,0,4
73,Apoptosis Modulation by HSP70 WP384,0.4054889886055789,2.646532438478747,2.38892310188642,['CYCS'],0.9415014663676738,0,0,1
74,BDNF-TrkB Signaling WP3676,0.4054889886055789,2.646532438478747,2.38892310188642,['HRAS'],0.9415014663676738,0,0,1
75,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.4054889886055789,2.646532438478747,2.38892310188642,['H3F3B'],0.9415014663676738,0,0,1
76,Eicosanoid Synthesis WP167,0.4054889886055789,2.646532438478747,2.38892310188642,['PNPLA3'],0.9415014663676738,0,0,1
77,ERK Pathway in Huntington's Disease WP3853,0.4054889886055789,2.646532438478747,2.38892310188642,['HRAS'],0.9415014663676738,0,0,1
78,Fatty acid beta-oxidation WP143,0.4054889886055789,2.646532438478747,2.38892310188642,['TPI1'],0.9415014663676738,0,0,1
79,Genes targeted by miRNAs in adipocytes WP1992,0.4054889886055789,2.646532438478747,2.38892310188642,['TMSB4X'],0.9415014663676738,0,0,1
80,Glutathione metabolism WP100,0.4054889886055789,2.646532438478747,2.38892310188642,['GPX4'],0.9415014663676738,0,0,1
81,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.4054889886055789,2.646532438478747,2.38892310188642,['HRAS'],0.9415014663676738,0,0,1
82,Matrix Metalloproteinases WP129,0.4054889886055789,2.646532438478747,2.38892310188642,['MMP15'],0.9415014663676738,0,0,1
83,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.4054889886055789,2.646532438478747,2.38892310188642,['B4GALNT1'],0.9415014663676738,0,0,1
84,miRNA regulation of p53 pathway in prostate cancer WP3982,0.4054889886055789,2.646532438478747,2.38892310188642,['EI24'],0.9415014663676738,0,0,1
85,Nanomaterial induced apoptosis WP2507,0.4054889886055789,2.646532438478747,2.38892310188642,['CYCS'],0.9415014663676738,0,0,1
86,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.4054889886055789,2.646532438478747,2.38892310188642,['EGLN2'],0.9415014663676738,0,0,1
87,RalA downstream regulated genes WP2290,0.4054889886055789,2.646532438478747,2.38892310188642,['HRAS'],0.9415014663676738,0,0,1
88,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.4054889886055789,2.646532438478747,2.38892310188642,['SFRP4'],0.9415014663676738,0,0,1
89,Rett syndrome causing genes WP4312,0.4054889886055789,2.646532438478747,2.38892310188642,['TBL1X'],0.9415014663676738,0,0,1
90,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.4319140283645033,1.51249199231262,1.2697804647409472,"['H3F3B', 'H2AFZ']",0.9415014663676738,0,0,2
91,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.4319140283645033,1.51249199231262,1.2697804647409472,"['MYO1E', 'YWHAQ']",0.9415014663676738,0,0,2
92,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.43546576674979565,1.3235955056179776,1.100356686548402,"['TMSB4X', 'NEFH', 'PFN2']",0.9415014663676738,0,0,3
93,Insulin Signaling WP481,0.47293813838153775,1.1761761761761762,0.880709764293968,"['XBP1', 'HRAS', 'VAMP2', 'ARF6']",0.9415014663676738,0,0,4
94,TNF-alpha signaling pathway WP231,0.480047725714299,1.2212618841832326,0.8962471554026624,"['BAD', 'TXN', 'HRAS']",0.9415014663676738,0,0,3
95,Glycolysis and Gluconeogenesis WP534,0.480047725714299,1.2212618841832326,0.8962471554026624,"['TPI1', 'MPC2', 'PGK1']",0.9415014663676738,0,0,3
96,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.48897798193546604,1.3228699551569507,0.9464311932070033,"['BAD', 'HRAS']",0.9415014663676738,0,0,2
97,Genotoxicity pathway WP4286,0.48897798193546604,1.3228699551569507,0.9464311932070033,"['RPS27', 'EI24']",0.9415014663676738,0,0,2
98,NO/cGMP/PKG mediated Neuroprotection WP4008,0.48897798193546604,1.3228699551569507,0.9464311932070033,"['BAD', 'CYCS']",0.9415014663676738,0,0,2
99,Retinoblastoma gene in cancer WP2446,0.48897798193546604,1.3228699551569507,0.9464311932070033,"['H2AFZ', 'DCK']",0.9415014663676738,0,0,2
100,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5001709960299674,1.7636092468307234,1.2218377398020197,['HRAS'],0.9415014663676738,0,0,1
101,Blood Clotting Cascade WP272,0.5001709960299674,1.7636092468307234,1.2218377398020197,['F8A1'],0.9415014663676738,0,0,1
102,Tumor suppressor activity of SMARCB1 WP4204,0.5001709960299674,1.7636092468307234,1.2218377398020197,['H3F3B'],0.9415014663676738,0,0,1
103,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.5001709960299674,1.7636092468307234,1.2218377398020197,['PPIB'],0.9415014663676738,0,0,1
104,Development and heterogeneity of the ILC family WP3893,0.5001709960299674,1.7636092468307234,1.2218377398020197,['IL18'],0.9415014663676738,0,0,1
105,Ganglio Sphingolipid Metabolism WP1423,0.5001709960299674,1.7636092468307234,1.2218377398020197,['B4GALNT1'],0.9415014663676738,0,0,1
106,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5001709960299674,1.7636092468307234,1.2218377398020197,['BAD'],0.9415014663676738,0,0,1
107,Hypertrophy Model WP516,0.5001709960299674,1.7636092468307234,1.2218377398020197,['IL18'],0.9415014663676738,0,0,1
108,IL-7 signaling pathway WP205,0.5001709960299674,1.7636092468307234,1.2218377398020197,['BAD'],0.9415014663676738,0,0,1
109,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5001709960299674,1.7636092468307234,1.2218377398020197,['SUPT4H1'],0.9415014663676738,0,0,1
110,Integrated Cancer Pathway WP1971,0.5001709960299674,1.7636092468307234,1.2218377398020197,['BAD'],0.9415014663676738,0,0,1
111,MAPK Cascade WP422,0.5001709960299674,1.7636092468307234,1.2218377398020197,['HRAS'],0.9415014663676738,0,0,1
112,Methionine De Novo and Salvage Pathway WP3580,0.5001709960299674,1.7636092468307234,1.2218377398020197,['TXN'],0.9415014663676738,0,0,1
113,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5001709960299674,1.7636092468307234,1.2218377398020197,['ANAPC11'],0.9415014663676738,0,0,1
114,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5001709960299674,1.7636092468307234,1.2218377398020197,['HRAS'],0.9415014663676738,0,0,1
115,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5423045524981709,1.175386148480319,0.7192511430751399,"['HRAS', 'MYL12B']",0.9415014663676738,0,0,2
116,Ectoderm Differentiation WP2858,0.5423045524981709,1.175386148480319,0.7192511430751399,"['TBL1X', 'LY6E']",0.9415014663676738,0,0,2
117,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5423045524981709,1.175386148480319,0.7192511430751399,"['BAD', 'HRAS']",0.9415014663676738,0,0,2
118,Glucocorticoid Receptor Pathway WP2880,0.5423045524981709,1.175386148480319,0.7192511430751399,"['GADD45B', 'TSC22D3']",0.9415014663676738,0,0,2
119,Modulators of TCR signaling and T cell activation WP5072,0.5423045524981709,1.175386148480319,0.7192511430751399,"['NDUFB10', 'ELOB']",0.9415014663676738,0,0,2
120,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5423045524981709,1.175386148480319,0.7192511430751399,"['IFI27L2', 'HRAS']",0.9415014663676738,0,0,2
121,Adipogenesis WP236,0.545386152605475,1.0576576576576577,0.6412167989458353,"['SFRP4', 'GADD45B', 'PNPLA3', 'IL6ST']",0.9415014663676738,0,0,4
122,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5798021920284063,1.3221476510067114,0.7206607484713417,['HRAS'],0.9415014663676738,0,0,1
123,Alpha 6 Beta 4 signaling pathway WP244,0.5798021920284063,1.3221476510067114,0.7206607484713417,['HRAS'],0.9415014663676738,0,0,1
124,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5798021920284063,1.3221476510067114,0.7206607484713417,['HRAS'],0.9415014663676738,0,0,1
125,Glycerolipids and Glycerophospholipids WP4722,0.5798021920284063,1.3221476510067114,0.7206607484713417,['PNPLA3'],0.9415014663676738,0,0,1
126,HIF1A and PPARG regulation of glycolysis WP2456,0.5798021920284063,1.3221476510067114,0.7206607484713417,['TPI1'],0.9415014663676738,0,0,1
127,IL-2 signaling pathway WP49,0.5798021920284063,1.3221476510067114,0.7206607484713417,['HRAS'],0.9415014663676738,0,0,1
128,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.5798021920284063,1.3221476510067114,0.7206607484713417,['YWHAQ'],0.9415014663676738,0,0,1
129,miRNA regulation of prostate cancer signaling pathways WP3981,0.5798021920284063,1.3221476510067114,0.7206607484713417,['BAD'],0.9415014663676738,0,0,1
130,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.5798021920284063,1.3221476510067114,0.7206607484713417,['EIF1'],0.9415014663676738,0,0,1
131,Pathways affected in adenoid cystic carcinoma WP3651,0.5798021920284063,1.3221476510067114,0.7206607484713417,['HRAS'],0.9415014663676738,0,0,1
132,PDGFR-beta pathway WP3972,0.5798021920284063,1.3221476510067114,0.7206607484713417,['HRAS'],0.9415014663676738,0,0,1
133,Regulation of Microtubule Cytoskeleton WP2038,0.5798021920284063,1.3221476510067114,0.7206607484713417,['CFL2'],0.9415014663676738,0,0,1
134,Small cell lung cancer WP4658,0.5916368537478831,1.0573991031390135,0.5549888777529277,"['GADD45B', 'CYCS']",0.9415014663676738,0,0,2
135,Apoptosis WP254,0.5916368537478831,1.0573991031390135,0.5549888777529277,"['BAD', 'CYCS']",0.9415014663676738,0,0,2
136,Complement system WP2806,0.5916368537478831,1.0573991031390135,0.5549888777529277,"['RPS19', 'TXN']",0.9415014663676738,0,0,2
137,Glioblastoma signaling pathways WP2261,0.5916368537478831,1.0573991031390135,0.5549888777529277,"['FOXO4', 'HRAS']",0.9415014663676738,0,0,2
138,Androgen receptor signaling pathway WP138,0.6023896729813109,0.9910112359550561,0.5022947840089935,"['BAG1', 'DSTN', 'PARK7']",0.9415014663676738,0,0,3
139,Regulation of Actin Cytoskeleton WP51,0.6023896729813109,0.9910112359550561,0.5022947840089935,"['CFL2', 'TMSB4X', 'BRK1']",0.9415014663676738,0,0,3
140,DNA damage response (only ATM dependent) WP710,0.6368938447657962,0.9608642478597635,0.43349610197367777,"['BAD', 'HRAS']",0.9415014663676738,0,0,2
141,ESC Pluripotency Pathways WP3931,0.6368938447657962,0.9608642478597635,0.43349610197367777,"['IL6ST', 'HRAS']",0.9415014663676738,0,0,2
142,Integrated breast cancer pathway WP1984,0.6368938447657962,0.9608642478597635,0.43349610197367777,"['BAD', 'FAU']",0.9415014663676738,0,0,2
143,Oncostatin M Signaling Pathway WP2374,0.6368938447657962,0.9608642478597635,0.43349610197367777,"['IL6ST', 'HRAS']",0.9415014663676738,0,0,2
144,Pancreatic adenocarcinoma pathway WP4263,0.6368938447657962,0.9608642478597635,0.43349610197367777,"['GADD45B', 'BAD']",0.9415014663676738,0,0,2
145,Proteasome Degradation WP183,0.6368938447657962,0.9608642478597635,0.43349610197367777,"['H2AFZ', 'PSMB10']",0.9415014663676738,0,0,2
146,16p11.2 distal deletion syndrome WP4950,0.6467705725482281,1.0572706935123042,0.46072013570508563,['ATP2A1'],0.9415014663676738,0,0,1
147,Acute viral myocarditis WP4298,0.6467705725482281,1.0572706935123042,0.46072013570508563,['CYCS'],0.9415014663676738,0,0,1
148,Bladder cancer WP2828,0.6467705725482281,1.0572706935123042,0.46072013570508563,['HRAS'],0.9415014663676738,0,0,1
149,TYROBP causal network in microglia WP3945,0.6467705725482281,1.0572706935123042,0.46072013570508563,['IL18'],0.9415014663676738,0,0,1
150,Unfolded protein response WP4925,0.6467705725482281,1.0572706935123042,0.46072013570508563,['XBP1'],0.9415014663676738,0,0,1
151,DNA Replication WP466,0.6467705725482281,1.0572706935123042,0.46072013570508563,['POLD2'],0.9415014663676738,0,0,1
152,Endochondral Ossification with Skeletal Dysplasias WP4808,0.6467705725482281,1.0572706935123042,0.46072013570508563,['SLC38A2'],0.9415014663676738,0,0,1
153,Endochondral Ossification WP474,0.6467705725482281,1.0572706935123042,0.46072013570508563,['SLC38A2'],0.9415014663676738,0,0,1
154,Folate Metabolism WP176,0.6467705725482281,1.0572706935123042,0.46072013570508563,['GPX4'],0.9415014663676738,0,0,1
155,Nephrotic syndrome WP4758,0.6467705725482281,1.0572706935123042,0.46072013570508563,['MYO1E'],0.9415014663676738,0,0,1
156,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.6467705725482281,1.0572706935123042,0.46072013570508563,['PIN1'],0.9415014663676738,0,0,1
157,One-carbon metabolism and related pathways WP3940,0.6467705725482281,1.0572706935123042,0.46072013570508563,['GPX4'],0.9415014663676738,0,0,1
158,Physiological and pathological hypertrophy of the heart WP1528,0.6467705725482281,1.0572706935123042,0.46072013570508563,['IL6ST'],0.9415014663676738,0,0,1
159,7q11.23 copy number variation syndrome WP4932,0.6726384352553822,0.8801498127340824,0.34902106440939845,"['VAMP2', 'ATP5F1E', 'ATP5MC1']",0.9431757035689518,0,0,3
160,ErbB signaling pathway WP673,0.6781210793526224,0.8804185351270553,0.3419804643637355,"['BAD', 'HRAS']",0.9431757035689518,0,0,2
161,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.700542057417377,0.8443243243243244,0.3004957665433702,"['YWHAQ', 'SCN5A', 'VAMP2', 'YWHAH']",0.9431757035689518,0,0,4
162,Aryl Hydrocarbon Receptor Netpath WP2586,0.7030859642878493,0.8806860551826995,0.3102446599300321,['HRAS'],0.9431757035689518,0,0,1
163,Vitamin D-sensitive calcium signaling in depression WP4698,0.7030859642878493,0.8806860551826995,0.3102446599300321,['GPX4'],0.9431757035689518,0,0,1
164,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7030859642878493,0.8806860551826995,0.3102446599300321,['CYCS'],0.9431757035689518,0,0,1
165,G13 Signaling Pathway WP524,0.7030859642878493,0.8806860551826995,0.3102446599300321,['CFL2'],0.9431757035689518,0,0,1
166,Galanin receptor pathway WP4970,0.7030859642878493,0.8806860551826995,0.3102446599300321,['VAMP2'],0.9431757035689518,0,0,1
167,Glycolysis in senescence WP5049,0.7030859642878493,0.8806860551826995,0.3102446599300321,['PGK1'],0.9431757035689518,0,0,1
168,Prostaglandin Synthesis and Regulation WP98,0.7030859642878493,0.8806860551826995,0.3102446599300321,['S100A6'],0.9431757035689518,0,0,1
169,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7030859642878493,0.8806860551826995,0.3102446599300321,['IL6ST'],0.9431757035689518,0,0,1
170,Breast cancer pathway WP4262,0.7041700292301317,0.833471318746304,0.2923279240338111,"['SFRP4', 'GADD45B', 'HRAS']",0.9431757035689518,0,0,3
171,Gastrin signaling pathway WP4659,0.7041700292301317,0.833471318746304,0.2923279240338111,"['CHGA', 'BAD', 'HRAS']",0.9431757035689518,0,0,3
172,Chemokine signaling pathway WP3929,0.7154526247985483,0.8123490858916868,0.27200688254061967,"['GNG3', 'HRAS']",0.9431757035689518,0,0,2
173,Prolactin Signaling Pathway WP2037,0.7154526247985483,0.8123490858916868,0.27200688254061967,"['PPIB', 'HRAS']",0.9431757035689518,0,0,2
174,Fragile X Syndrome  WP4549,0.7490818536437739,0.7540038436899423,0.21783700168842596,"['AP2S1', 'AP2M1']",0.9431757035689518,0,0,2
175,Mesodermal commitment pathway WP2857,0.7490818536437739,0.7540038436899423,0.21783700168842596,"['ARL4A', 'RPL38']",0.9431757035689518,0,0,2
176,Sleep regulation WP3591,0.7504397989266007,0.7545541706615532,0.2166293677883342,['IL18'],0.9431757035689518,0,0,1
177,CAMKK2  Pathway WP4874,0.7504397989266007,0.7545541706615532,0.2166293677883342,['FIS1'],0.9431757035689518,0,0,1
178,Zinc homeostasis WP3529,0.7504397989266007,0.7545541706615532,0.2166293677883342,['MT3'],0.9431757035689518,0,0,1
179,Ferroptosis WP4313,0.7504397989266007,0.7545541706615532,0.2166293677883342,['GPX4'],0.9431757035689518,0,0,1
180,IL-4 signaling pathway WP395,0.7504397989266007,0.7545541706615532,0.2166293677883342,['BAD'],0.9431757035689518,0,0,1
181,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.7504397989266007,0.7545541706615532,0.2166293677883342,['NDRG1'],0.9431757035689518,0,0,1
182,p38 MAPK Signaling Pathway WP400,0.7504397989266007,0.7545541706615532,0.2166293677883342,['HRAS'],0.9431757035689518,0,0,1
183,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7504397989266007,0.7545541706615532,0.2166293677883342,['PGK1'],0.9431757035689518,0,0,1
184,Translation Factors WP107,0.7792392580792854,0.7034379671150972,0.17546355846747197,"['EEF1B2', 'EIF1']",0.9472902699340067,0,0,2
185,G Protein Signaling Pathways WP35,0.7792392580792854,0.7034379671150972,0.17546355846747197,"['GNG3', 'HRAS']",0.9472902699340067,0,0,2
186,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7902554575122871,0.6599552572706935,0.15535282202781522,['BEX3'],0.9472902699340067,0,0,1
187,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7902554575122871,0.6599552572706935,0.15535282202781522,['XBP1'],0.9472902699340067,0,0,1
188,Head and Neck Squamous Cell Carcinoma WP4674,0.7902554575122871,0.6599552572706935,0.15535282202781522,['HRAS'],0.9472902699340067,0,0,1
189,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7902554575122871,0.6599552572706935,0.15535282202781522,['HRAS'],0.9472902699340067,0,0,1
190,PDGF Pathway WP2526,0.7902554575122871,0.6599552572706935,0.15535282202781522,['HRAS'],0.9472902699340067,0,0,1
191,Photodynamic therapy-induced unfolded protein response WP3613,0.7902554575122871,0.6599552572706935,0.15535282202781522,['XBP1'],0.9472902699340067,0,0,1
192,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8061757983922552,0.6591928251121076,0.14202536713931793,"['MMP15', 'HRAS']",0.9472902699340067,0,0,2
193,Metabolic reprogramming in colon cancer WP4290,0.8061757983922552,0.6591928251121076,0.14202536713931793,"['PGK1', 'SLC16A3']",0.9472902699340067,0,0,2
194,Vitamin D Receptor Pathway WP2877,0.8072969224742781,0.6873473375671715,0.14713614499606117,"['CDKN2D', 'DND1', 'S100A6']",0.9472902699340067,0,0,3
195,Focal Adhesion WP306,0.8072969224742781,0.6873473375671715,0.14713614499606117,"['BAD', 'HRAS', 'MYL12B']",0.9472902699340067,0,0,3
196,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8237306695078319,0.5863783246333582,0.11370559425645191,['HRAS'],0.9472902699340067,0,0,1
197,TGF-beta Receptor Signaling WP560,0.8237306695078319,0.5863783246333582,0.11370559425645191,['HRAS'],0.9472902699340067,0,0,1
198,Hippo-Merlin Signaling Dysregulation WP4541,0.8237306695078319,0.5863783246333582,0.11370559425645191,['HRAS'],0.9472902699340067,0,0,1
199,Integrin-mediated Cell Adhesion WP185,0.8237306695078319,0.5863783246333582,0.11370559425645191,['HRAS'],0.9472902699340067,0,0,1
200,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8237306695078319,0.5863783246333582,0.11370559425645191,['IL6ST'],0.9472902699340067,0,0,1
201,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8463723124129224,0.6318202247191012,0.10538504234805159,"['MARCKS', 'BAD', 'HRAS']",0.9604452948447758,0,0,3
202,Apoptosis Modulation and Signaling WP1772,0.8514219878435996,0.5854509217737918,0.09416825883284911,"['BAD', 'CYCS']",0.9604452948447758,0,0,2
203,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.851873218036236,0.5275167785234899,0.08457020719522945,['HRAS'],0.9604452948447758,0,0,1
204,Thermogenesis WP4321,0.851873218036236,0.5275167785234899,0.08457020719522945,['HRAS'],0.9604452948447758,0,0,1
205,Calcium Regulation in the Cardiac Cell WP536,0.8629170901803895,0.6374556374556375,0.09398433272832957,"['GJD2', 'GNG3', 'YWHAQ', 'YWHAH']",0.9635030214071745,0,0,4
206,Pathways in clear cell renal cell carcinoma WP4018,0.8702412640726755,0.5544016993155535,0.07705340417200764,"['TPI1', 'PGK1']",0.9635030214071745,0,0,2
207,G1 to S cell cycle control WP45,0.8755310064091282,0.479357331706325,0.06371843536987427,['CDKN2D'],0.9635030214071745,0,0,1
208,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8755310064091282,0.479357331706325,0.06371843536987427,['SFRP4'],0.9635030214071745,0,0,1
209,Regulation of toll-like receptor signaling pathway WP1449,0.8755310064091282,0.479357331706325,0.06371843536987427,['PELI3'],0.9635030214071745,0,0,1
210,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8954173741782309,0.43922445935868754,0.048519074647711144,['SFRP4'],0.9806952193380625,0,0,1
211,"GPCRs, Class A Rhodopsin-like WP455",0.904339520886388,0.5437427353738861,0.0546735565528343,"['GPR12', 'GPR22', 'OR6A2']",0.9849317127170445,0,0,3
212,T-cell receptor (TCR) signaling pathway WP69,0.9121324122118716,0.40526587506453277,0.037272347359335815,['HRAS'],0.9849317127170445,0,0,1
213,B Cell Receptor Signaling Pathway WP23,0.9121324122118716,0.40526587506453277,0.037272347359335815,['HRAS'],0.9849317127170445,0,0,1
214,Wnt signaling WP428,0.9261809079166482,0.37615851709811443,0.028845978629043537,['SFRP4'],0.985100977151878,0,0,1
215,Male infertility WP4673,0.9261809079166482,0.37615851709811443,0.028845978629043537,['DND1'],0.985100977151878,0,0,1
216,Proximal tubule transport WP4917,0.9261809079166482,0.37615851709811443,0.028845978629043537,['ATP6V1G1'],0.985100977151878,0,0,1
217,22q11.2 copy number variation syndrome WP4657,0.9379874521576578,0.35093214019388513,0.022466221963841824,['MRPL40'],0.985100977151878,0,0,1
218,Exercise-induced Circadian Regulation WP410,0.9379874521576578,0.35093214019388513,0.022466221963841824,['DNAJA1'],0.985100977151878,0,0,1
219,Pathogenic Escherichia coli infection WP2272,0.9379874521576578,0.35093214019388513,0.022466221963841824,['YWHAQ'],0.985100977151878,0,0,1
220,Corticotropin-releasing hormone signaling pathway WP2355,0.9479091562663646,0.3288590604026846,0.017592844255433702,['IL18'],0.9861406117338418,0,0,1
221,Ciliary landscape WP4352,0.9487577005871624,0.46278916060806347,0.024343558484982247,"['COX6C', 'DCAF11', 'LSM4']",0.9861406117338418,0,0,3
222,Myometrial relaxation and contraction pathways WP289,0.9549372390400028,0.4493739967897271,0.020720481730126968,"['GNG3', 'YWHAQ', 'YWHAH']",0.9861406117338418,0,0,3
223,NRF2 pathway WP2884,0.9581021292290791,0.38880584620494935,0.016641240136001927,"['TXN', 'SLC5A3']",0.9861406117338418,0,0,2
224,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.96041520447122,0.43670411985018726,0.017638297454927374,"['GNG3', 'BAD', 'HRAS']",0.9861406117338418,0,0,3
225,Metapathway biotransformation Phase I and II WP702,0.9691373380418136,0.27658071352878844,0.008670513689614254,['GPX4'],0.9867099936496914,0,0,1
226,PI3K-Akt signaling pathway WP4172,0.969549819847088,0.413364872856298,0.012782654941810447,"['GNG3', 'BAD', 'HRAS']",0.9867099936496914,0,0,3
227,Spinal Cord Injury WP2431,0.9740820899098965,0.2626398210290828,0.006896842296170321,['XYLT1'],0.9869554214946089,0,0,1
228,Nuclear Receptors Meta-Pathway WP2882,0.9784035333215801,0.42636514065085496,0.009308865627556126,"['GADD45B', 'TSC22D3', 'TXN', 'SLC5A3']",0.98698602045598,0,0,4
229,Circadian rhythm related genes WP3594,0.9981250617124715,0.14912112496005114,0.00027985534447750785,['RPS27A'],0.9986799583216257,0,0,1
230,MAPK Signaling Pathway WP382,0.9986799583216257,0.14093959731543623,0.00018616904509034693,['HRAS'],0.9986799583216257,0,0,1
